top of page
medical_managment-key.png

CANCER

GENETIC CANCER RISK

Endocrine

High Risk

Other

Elevated Risk

Renal

Elevated Risk

medical_managment-key.png

CANCER TYPE

AGE RANGE

CANCER RISK

RISK FOR GENERAL POPULATION 

Paraganglioma/Pheochromocytoma

To age 60

25% risk for tumors, only some of which will be malignant

<0.1%

Renal

To age 60

4%-5%

0.5%

Gastrointestinal Stromal Tumors (GIST)

To age 80

2%

<0.1%

SDHB

Associated Syndrome

Hereditary Pheochromocytoma-Paraganglioma syndrome (Hereditary PPGL syndrome)

Core Cancer Risk(s)

Paragangliomas and Pheochromocytomas (that often secrete hormones that cause high blood pressure, rapid and/or abnormal heartbeat, headaches, sweating, nausea, fatigue, and anxiety). Elevated Risk for renal cancer and gastrointestinal stromal tumors

Inheritance 

Autosomal Dominant 

Prevalence

Unknown

medical_managment-key.png

CANCER TYPE

PROCEDURE

AGE TO BEGIN

FREQUENCY

Paraganglioma/Pheochromocytoma

Clinical monitoring, including blood pressure measurement

6 to 8 years

Annually

Biochemical screening of serum and urine

6 to 8 years

Annually

Whole-body MRI with consideration of the head and neck

6 to 8 years

Every 2 years

Renal

Abdominal MRI (preferred) or CT, with and without IV contrast

12 years

Every 4 to 6 years

Gastrointestinal Stromal Tumors (GIST)

Complete blood count and attention to symptoms such as gastric bleeding, obstruction, abdominal pain, nausea, etc.

6 to 8 years

Annually

bottom of page